Drug repurposing, or identifying new uses for existing drugs, has emerged as an alternative to traditional drug discovery processes involving de novo synthesis. Drugs that are currently approved or under development for non-antibiotic indications may possess antibiotic properties, and therefore may have repurposing potential, either alone or in combination with an antibiotic. They might also serve as “antibiotic adjuvants” to enhance the activity of certain antibiotics.
Digital Object Identifier (DOI)
Published in Frontiers in Cellular and Infection Microbiology, Volume 11, 2021.
© 2021 Boyd, Teng and Frei. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Boyd, N. K., Teng, C., & Frei, C. R. (2021). Brief overview of approaches and challenges in new antibiotic development: A focus on drug repurposing. Frontiers in Cellular and Infection Microbiology, 11. https://doi.org/10.3389/fcimb.2021.684515